comparemela.com
  1. Home
  2. Live Updates
  3. Vivo Program Sciences - Breaking News

Latest Breaking News On - Vivo program sciences - Page 1 : comparemela.com

Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting

/PRNewswire/ Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data.

United statesSan diegoVic myerJamie schaferAmerican society of hematologyVivo program sciencesPrnewswire chroma medicine incAmerican societyAnnual meetingDurable multiplex epigenetic editingAssociate directorChroma medicine

Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting

Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data.

United statesSan diegoVic myerJamie schaferPrnewswire chroma medicine incVivo program sciencesAmerican society of hematologyEnhance allogeneicAmerican societyAnnual meetingDurable multiplex epigenetic editingAssociate director

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.